Your browser doesn't support javascript.
loading
Fabrication of Antibacterial Sponge Microneedles for Sampling Skin Interstitial Fluid.
Chen, Jianmin; Cai, Xiaozhen; Zhang, Wenqin; Zhu, Danhong; Ruan, Zhipeng; Jin, Nan.
Afiliación
  • Chen J; School of Pharmacy, Fujian Medical University, Putian 351100, China.
  • Cai X; Key Laboratory of Pharmaceutical Analysis and Laboratory Medicine, Putian University, Putian 351100, China.
  • Zhang W; School of Pharmacy and Medical technology, Putian University, Putian 351100, China.
  • Zhu D; School of Pharmacy and Medical technology, Putian University, Putian 351100, China.
  • Ruan Z; School of Pharmacy, Fujian Medical University, Putian 351100, China.
  • Jin N; School of Pharmacy and Medical technology, Putian University, Putian 351100, China.
Pharmaceutics ; 15(6)2023 Jun 14.
Article en En | MEDLINE | ID: mdl-37376179
Microneedles (MNs) have recently garnered extensive interest concerning direct interstitial fluid (ISF) extraction or their integration into medical devices for continuous biomarker monitoring, owing to their advantages of painlessness, minimal invasiveness, and ease of use. However, micropores created by MN insertion may provide pathways for bacterial infiltration into the skin, causing local or systemic infection, especially with long-term in situ monitoring. To address this, we developed a novel antibacterial sponge MNs (SMNs@PDA-AgNPs) by depositing silver nanoparticles (AgNPs) on polydopamine (PDA)-coated SMNs. The physicochemical properties of SMNs@PDA-AgNPs were characterized regarding morphology, composition, mechanical strength, and liquid absorption capacity. The antibacterial effects were evaluated and optimized through agar diffusion assays in vitro. Wound healing and bacterial inhibition were further examined in vivo during MN application. Finally, the ISF sampling ability and biosafety of SMNs@PDA-AgNPs were assessed in vivo. The results demonstrate that antibacterial SMNs enable direct ISF extraction while preventing infection risks. SMNs@PDA-AgNPs could potentially be used for direct sampling or combined with medical devices for real-time diagnosis and management of chronic diseases.
Palabras clave

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Idioma: En Revista: Pharmaceutics Año: 2023 Tipo del documento: Article País de afiliación: China Pais de publicación: Suiza

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Idioma: En Revista: Pharmaceutics Año: 2023 Tipo del documento: Article País de afiliación: China Pais de publicación: Suiza